A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
for
Small Cell Lung Cancer
Location: Boston MA, Hackensack NJ, Miami FL, Buffalo NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06780137
Phase1, Phase2, Recruiting
Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)
Location: Boston MA, New York NY, Ottawa, Washington D.C. DC,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06586515
Phase1, Recruiting
Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs
for
Non-small Cell Lung Cancer (NSCLC)
Location: Nashville TN, Houston TX
Sponsor: Pierre Fabre Medicament
Sex: All
Age: 18+
Code: NCT06567015
Phase1, Phase2, Recruiting
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
for
Advanced Solid Tumor, Non Small Cell Lung Cancer,
Location: Boston MA, New Haven CT, Lake Success NY, New York NY,
Sponsor: Synthekine
Sex: All
Age: 18+
Code: NCT05098132
Phase1, Phase2, Recruiting
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
for
Non Small Cell Lung Cancer, Esophageal Cancer,
Location: Boston MA, New Haven CT, New York NY,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT05983432
Phase1, Recruiting
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
for
Triple Negative Breast Cancer, Non Small Cell Lung Cancer,
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases
for
Carcinoma, Non-Small-Cell Lung Cancer,
Location: Norfolk VA, Pittsburgh PA, Tyler TX, Beverly Hills CA
Sponsor: Kiromic BioPharma Inc.
Sex: All
Age: 18+
Code: NCT06069570
Phase1, Recruiting
Stereotactic Radiotherapy (SBRT) of Lung Metastasis
for
Non-small Cell Lung Cancer, Metastasis From Other Cancers
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT01803542
Phase2, Recruiting
Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects